Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Addex Therapeutics (ADXN) shares

Learn how to easily invest in Addex Therapeutics shares.

Addex Therapeutics is a biotechnology business based in the US. Addex Therapeutics stocks (ADXN.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $9.99 – a decrease of 3.05% over the previous week. Addex Therapeutics employs 27 staff and has a trailing 12-month revenue of around $4.6 million.

How to buy shares in Addex Therapeutics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ADXN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Addex Therapeutics stock price (NASDAQ:ADXN)

Use our graph to track the performance of ADXN stocks over time.

Addex Therapeutics shares at a glance

Information last updated 2022-01-17.
Latest market close$5.84
52-week range$5.81 - $18.87
50-day moving average $6.92
200-day moving average $8.97
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.68

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Addex Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Addex Therapeutics price performance over time

Historical closes compared with the close of $5.8364 from 2022-01-19

1 week (2022-01-13) -3.05%
1 month (2021-12-20) -12.63%
3 months (2021-10-20) -28.95%
6 months (2021-07-20) -35.81%
1 year (2021-01-20) -45.07%
2 years (2020-01-16) N/A
3 years (2019-01-16) N/A
5 years (2017-01-16) N/A

Addex Therapeutics financials

Revenue TTM $4.6 million
Gross profit TTM $-6,470,057
Return on assets TTM -43.47%
Return on equity TTM -89.76%
Profit margin -281.08%
Book value $2.35
Market capitalisation $39.5 million

TTM: trailing 12 months

Addex Therapeutics share dividends

We're not expecting Addex Therapeutics to pay a dividend over the next 12 months.

Addex Therapeutics share price volatility

Over the last 12 months, Addex Therapeutics's shares have ranged in value from as little as $5.8117 up to $18.87. A popular way to gauge a stock's volatility is its "beta".

ADXN.US volatility(beta: 1.33)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Addex Therapeutics's is 1.3315. This would suggest that Addex Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Addex Therapeutics overview

Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc. ; Indivior PLC; and The Charcot?Marie?Tooth Association. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site